Abingworth seeks to identify and invest in the best opportunities in the life sciences and healthcare markets. Our investments and expertise are balanced across all stages of company development including Venture Capital, Growth Equity and Public Markets. We invest in platform and enabling technologies, medical devices, instrumentation, companies developing therapeutics and healthcare services businesses.
We seek long-term involvement with our investments and provide much more than financial backing. Our objective is to be supportive and help identify solutions. Abingworth’s team has a strong scientific background in addition to business, financial and other specialist skills. These include legal, investment banking as well as operating and recruiting capabilities. Our resources are complimented by a network of leading scientific and industry consultants. These skill sets and contacts are made available to our portfolio companies.
| Sector: |
Life sciences and Healthcare |
| Size of investment: |
$20-$80 million* |
| Investment Stage: |
Early and late-stage venture, growth equity and public markets |
| Ownership: |
Minority and majority |
| Geography: |
Primarily US, UK and Europe |
| Holding Period: |
3-8 years |
*Monies may be invested over more than one round of financing.
